Clinical trials
Phase 1/2 trials in Belgium
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
447 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 3 |
| 2001 | 3 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 9 |
| 2006 | 8 |
| 2007 | 14 |
| 2008 | 18 |
| 2009 | 17 |
| 2010 | 16 |
| 2011 | 10 |
| 2012 | 24 |
| 2013 | 16 |
| 2014 | 17 |
| 2015 | 18 |
| 2016 | 28 |
| 2017 | 28 |
| 2018 | 32 |
| 2019 | 28 |
| 2020 | 19 |
| 2021 | 25 |
| 2022 | 30 |
| 2023 | 23 |
| 2024 | 22 |
| 2025 | 23 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 198 |
| Terminated | 84 |
| Recruiting | 73 |
| Active, not recruiting | 53 |
| Unknown status | 28 |
| Withdrawn | 6 |
| Suspended | 2 |
| Not yet recruiting | 2 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 19 |
| Bristol-Myers Squibb | 16 |
| GlaxoSmithKline | 14 |
| Pfizer | 13 |
| Hoffmann-La Roche | 11 |
| Universitair Ziekenhuis Brussel | 11 |
| Eli Lilly and Company | 9 |
| Genmab | 9 |
| Amgen | 8 |
| Cliniques universitaires Saint-Luc- Université Catholique de Louvain | 8 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 45 |
| Breast Neoplasms | 33 |
| Colorectal Neoplasms | 33 |
| Neoplasms | 31 |
| Ovarian Neoplasms | 28 |
| Neoplasm Metastasis | 26 |
| Melanoma | 24 |
| Recurrence | 20 |
| Squamous Cell Carcinoma of Head and Neck | 18 |
| Endometrial Neoplasms | 16 |
Trials
Showing 26 to 50 of 447. Each trial links to its page on Pharma Observatory.
347 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.